COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

New clinical trial focused on pulmonary complications in COVID-19 patients

The Montreal Heart Institute has launched a new clinical trial aimed at improving care for patients who have been diagnosed with COVID-19.

March 23, 2020
ECG rhythm strip from a 6-lead ECG

Heart patients have cause to be hypervigilant about COVID-19

Of COVID-19 patients who develop serious heart complications, most don’t see this problem until late in the disease’s progression. However, some are turning up with extensive heart inflammation at the outset.

March 20, 2020
heart

4 key considerations for managing cardiovascular patients with or without COVID-19

Cardiovascular care professionals must consider the concerns and views of healthcare workers, members of hospital/health system leadership and, not least, patients—whether the latter are infected with COVID-19 or not.

March 20, 2020

What the COVID-19 pandemic means for cath labs

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

March 19, 2020
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

Making an impact: AHA outlines its role during COVID-19 pandemic

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

March 18, 2020

A new warning for heart patients as COVID-19 continues to spread

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.

March 18, 2020
coronavirus_2.jpg

Patients with COVID-19 should keep taking key CVD medications

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 

March 17, 2020
Coronavirus

ACC issues COVID-19 guidance for cardiologists

Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.

March 12, 2020

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup